在不兼容的输血后,CD47调节抗原调节和红细胞清除
Ryan P Jajosky1,2, Mischa L Covington1,2, Jun Liu1,2
1Joint Program in Transfusion Medicine, Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States.
Frontiers in immunology
|April 21, 2025
概括
CD47蛋白水平影响红细胞 (RBC) 输血结果. 红细胞上较低的CD47水平促进了抗体介导的去除,影响了输血兼容性和抗原调制.
科学领域:
- 免疫学 免疫学 免疫学
- 血液学 血液学 血液学
- 细胞生物学 细胞生物学
背景情况:
- 红细胞 (RBC) 抗体可以导致不兼容的输血红细胞的快速去除.
- 抗体结合还可以调节目标抗原,使红细胞抵抗清除.
- 调节抗体诱导的红细胞去除和抗原调节的因素尚未完全理解.
研究的目的:
- 研究CD47在抗体介导的红细胞清除和抗原调制中的作用.
- 了解CD47如何影响不兼容红细胞输血后果.
主要方法:
- 生成的转基因小鼠 (HOD CD47 WT,HOD CD47 HET,HOD CD47 KO) 表达不同水平的CD47.
- 利用抗HEL免疫模型研究抗体介导作用.
- 评估了不同CD47遗传背景的红细胞清除率和抗原调制率.
主要成果:
- 野生型CD47红细胞的抗体接触导致了抗原调制,没有显著的清除.
- 抗体与异合体CD47红细胞结合导致可检测的红细胞去除与类似的抗原调制.
- CD47淘汰赛红细胞显示了加速清除,在抗体存在时增强了清除和调节.
结论:
- CD47在决定不兼容红细胞输血的结果方面发挥着至关重要的作用.
- 在抗体参与后,CD47水平调节了红细胞清除和抗原调节之间的平衡.
- 结果表明CD47是改善输血安全的潜在目标.
更多相关视频
10:15The Use of the Ex Vivo Chandler Loop Apparatus to Assess the Biocompatibility of Modified Polymeric Blood Conduits
Published on: August 20, 2014
11.5K
11:31Antigens Protected Functional Red Blood Cells By The Membrane Grafting Of Compact Hyperbranched Polyglycerols
Published on: January 2, 2013
18.0K
相关概念视频
02:45Blood Transfusion and Agglutination
10.6K
Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
10.6K
01:01Regulation of Hematopoietic Stem Cells
3.1K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.1K
01:40Cell-mediated Immune Responses
65.3K
Overview
65.3K
01:19Rh Blood Group
1.2K
The Rhesus (Rh) antigen is crucial in determining blood groups and ensuring compatibility during blood transfusions.
1.2K
01:10Blood Typing
1.0K
Understanding an individual's blood group is a critical component of transfusion medicine. It ensures compatibility in blood transfusions, organ transplants, and even during pregnancy. Determining these blood groups involves the ABO and Rh blood typing systems, utilizing specific antigens and corresponding anti-sera to identify an individual's blood type.
Antigens are protein molecules that reside on the surface of red blood cells (RBCs). The ABO and Rh blood typing systems target...
Antigens are protein molecules that reside on the surface of red blood cells (RBCs). The ABO and Rh blood typing systems target...
1.0K
01:22T Cell Activation and Clonal Selection
531
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
531